SOBRE ESTE EPISÓDIO
Host: Alexandria May, PharmD, BCPS
Guest: Kaitlin Batley, MD
Guest: Kaitlin Batley, MD
Fatigue and muscle weakness may seem routine, but when do they signal an underlying condition like thymidine kinase 2 deficiency (TK2d)? To find out, Dr. Alexandria May speaks with Dr. Kaitlin Batley, Director of the Pediatric Neuromuscular Program at Children’s Health and an Assistant Professor of Pediatrics and Neurology at UT Southwestern Medical Center. They discuss how multisystem involvement can help distinguish TK2d from more common neuromuscular disorders and how we can achieve diagnostic clarity through advanced genetic testing, metabolic evaluation, and muscle biopsy.
Inglês
Estados Unidos da América
NESTE EPISÓDIO
TRANSCRIÇÃO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de NeuroFrontiers.
OUTROS EPISÓDIOS NESTE PODCAST
Guest: Henry Kaminski, MD
Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment de…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Cxplore how cell-based therapies are reshaping treatment strategies for multiple sclerosis (MS). Hear from Dr. Mark Freedman as he examines the scientific rationale behind emerging strategies. Dr. Freedman is a Profes…
Host: Brian P. McDonough, MD, FAAFP
Guest: Austin Larson, MD
Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights into its global genetic prevalence and variability across genetic ancestries. By combining clinical literature with large genomic databases, in…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune system replacement via autologous stem cells, investigational mesenchymal repair strategies, and CAR T-cell approaches changing the treatment …
Aviso: O podcast e a arte incorporada nesta página são de ReachMD, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.
